-

Marsh McLennan Appoints Bruce Broussard to its Board of Directors

NEW YORK--(BUSINESS WIRE)--The Board of Directors of Marsh McLennan (NYSE: MMC), a global leader in risk, strategy and people, today appointed Bruce Broussard as a director, effective immediately. The Company’s Board now consists of 12 directors.

Commenting on Mr. Broussard’s appointment, H. Edward Hanway, Chair of the Company’s Board of Directors, said, “We are delighted to welcome Bruce to the Board. His appointment underscores our commitment to enriching our Board with broad industry expertise.”

John Doyle, President and CEO of Marsh McLennan, said, “Bruce is a terrific addition to Marsh McLennan’s Board. He brings a wealth of knowledge in the insurance and healthcare sectors, along with valuable leadership experience as a Chief Executive and Financial Officer, which will enhance our Board's perspective on an array of important issues.”

Mr. Broussard has over 30 years of experience leading public and private healthcare organizations. He was named President of Humana in 2011 and served as Chief Executive Officer from 2013 to 2024. Prior to that, he was Chief Executive Officer of McKesson Specialty/US Oncology. He joined US Oncology, which was acquired by McKesson Specialty, in 2000, and held various leadership roles, including Chief Financial Officer, President, Chief Executive Officer and Chairman of the Board.

Mr. Broussard also serves on the boards of directors of HP Inc., Cleveland Clinic and One Call. Additionally, he holds leadership positions in numerous advocacy organizations, including The Business Council and the American Heart Association’s CEO Roundtable. He is also the Chair of the Board of Directors of the Trust for the National Mall, a nonprofit philanthropic partner of the National Park Service dedicated to restoring and preserving the National Mall.

About Marsh McLennan

Marsh McLennan (NYSE: MMC) is a global leader in risk, strategy and people, advising clients in 130 countries across four businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman. With annual revenue of over $24 billion and more than 90,000 colleagues, Marsh McLennan helps build the confidence to thrive through the power of perspective. For more information, visit marshmclennan.com, or follow on LinkedIn and X.

Contacts

Media Contact:
Erick Gustafson
Marsh McLennan
+1 202 263 7788
erick.gustafson@mmc.com

Investor Contact:
Jay Gelb
Marsh McLennan
+1 212 345 1569
jay.gelb@mmc.com

Marsh McLennan

NYSE:MMC

Release Versions

Contacts

Media Contact:
Erick Gustafson
Marsh McLennan
+1 202 263 7788
erick.gustafson@mmc.com

Investor Contact:
Jay Gelb
Marsh McLennan
+1 212 345 1569
jay.gelb@mmc.com

More News From Marsh McLennan

Marsh Reports Second Quarter 2026 Results

NEW YORK--(BUSINESS WIRE)--Marsh (NYSE: MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today reported financial results for the second quarter ended June 30, 2026. John Doyle, President and CEO, said: "I am pleased with our solid results in the quarter and our execution in a dynamic environment. Our performance in the first half underscores strong demand for Marsh's expertise and capabilities across risk, people, strategy, and investm...

Marsh Survey Reveals That Insurers’ Private Credit Appetite Continues to Grow, but Discipline Remains Paramount

NEW YORK--(BUSINESS WIRE)--Marsh (NYSE: MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today released the findings of its 2026 Global Insurance Investments Survey, which shows that insurers’ demand for private credit remains strong but increasingly selective. More than half (57%) of the insurers surveyed plan to increase their exposure to private credit in the next 12 to 24 months, making it the leading area of planned investment grow...

Marsh Increases Quarterly Cash Dividend

NEW YORK--(BUSINESS WIRE)--The Board of Directors of Marsh (NYSE: MRSH) today declared a 10% increase in the quarterly dividend from $0.900 to $0.990 per share on outstanding common stock, payable on August 14, 2026, to stockholders of record on July 23, 2026. About Marsh Marsh (NYSE: MRSH) is a global leader in risk, reinsurance and capital, people and investments, and management consulting, advising clients in 130 countries. With annual revenue of $27 billion and more than 95,000 colleagues,...
Back to Newsroom